Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in Denmark
Retrospective non-interventional study of HR+/HER2- locally advanced or metastatic breast cancer patients treated with palbociclib in Denmar…
-
CLINICAL_TRIALS trial_result · 2024-02-29Clinical Trial Update: Altering Lipids for Tolerance of Aromatase Inhibitor Therapy [Phase 2]
Phase 2 clinical trial updating on altering lipids to improve tolerance of aromatase inhibitor therapy in breast cancer.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients [Phase 3]
A Phase 3 trial evaluating whether rosuvastatin can protect against chemotherapy-induced cardiotoxicity in HER2-positive breast cancer patie…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients [Phase 1, Phase 2]
A clinical trial update for Ficus septica leaf fraction used as a complementary therapy in stage IV breast cancer (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC). [Phase 4]
Phase 4 trial exploring the efficacy and safety of pirotinib (pyrotinib) plus trastuzumab and taxanes in trastuzumab-treated HER2-positive a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Exercise Program in Cancer and Cognition [NA]
A completed clinical trial evaluating an exercise program’s effects on cognition in individuals with breast cancer; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Stockholm Mammography Risk Stratified Trial [Phase 3]
Phase 3 clinical trial update for a breast cancer study at Karolinska Institutet; the trial is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: TOPS for African American Breast Cancer Survivors [NA]
A completed clinical trial evaluating the TOPS program for feasibility and acceptability among African American breast cancer survivors, wit…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer [Phase 2]
Phase 2 trial update of palbociclib in molecularly characterized ER-positive/HER2-negative metastatic breast cancer has completed with resul…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced Breast Cancer Clinical Trial [Phase 3]
Phase 3 trial evaluating disitamab vedotin plus pyrotinib versus THP in first-line HER2-positive metastatic breast cancer is currently recru…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer [Phase 1, Phase 2]
Phase 1/Phase 2 trial update investigating dalpiciclib with fulvestrant, trastuzumab, and pertuzumab in HR-positive, HER2-positive metastati…
-
CLINICAL_TRIALS withdrawal · 2024-02-26Clinical Trial Update: A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer [Phase 3]
A Phase 3 neoadjuvant trial comparing TCbHP vs ECHP-THP in HER2-positive breast cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: MEtronomic TrEatment Option in Advanced bReast cAncer [Phase 2]
Phase 2 clinical trial update for a treatment option in advanced breast cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating enobosarm in combination with abemaciclib for ER+HER2- metastatic breast cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer [Phase 1, Phase 2]
Clinical trial update for GQ1001 combined with Pyrotinib in HER2-positive metastatic breast cancer across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: First-line Nab-paclitaxel Plus Cisplatin Plus Carilizumab in mTNBC Patients [Phase 2]
Phase 2 trial update on first-line nab-paclitaxel, cisplatin, and carilizumab in metastatic triple-negative breast cancer (mTNBC).
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast Cancer [Phase 2]
Phase 2 trial update of MYOCET (doxorubicin liposome) in HER2-positive breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Evaluation of the Effect of Nigella Sativa for the Prophylaxis to Radiation Induced Dermatitis in Breast Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating Nigella Sativa for prevention of radiation-induced dermatitis in breast cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy [Phase 4]
Phase 4 trial update evaluating pegfilgrastim given on day 3 after chemotherapy to reduce neutropenia in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy [Phase 1]
Phase 1 trial of F-627 in women with breast cancer receiving myelotoxic chemotherapy has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: Accelerated Hypofractionated Radiotherapy (AHF-RT) for the Treatment of Breast Cancer [NA]
Clinical trial update on accelerated hypofractionated radiotherapy for breast cancer; study completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer and Lymphoma? [Phase 3]
Phase 3 trial update investigating PROACT to prevent chemotherapy-related heart damage in patients with breast cancer and non-Hodgkin lympho…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant [Phase 2]
A Phase 2 decentralized trial in advanced breast cancer with a PIK3CA mutation evaluated alpelisib in combination with fulvestrant; the stud…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer [Phase 3]
Phase 3 clinical trial evaluating patient-derived organoid-guided personalized treatment versus physician's choice in breast cancer is curre…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases [Phase 2, Phase 3]
A Phase 2/Phase 3 trial investigating RC48-ADC given IV in HER2-positive metastatic breast cancer, with or without liver metastases.